Hsp90α/β associates with the GSK3β/axin1/phospho-β-catenin complex in the human MCF-7 epithelial breast cancer model
► Phosphorylation and degradation of β-catenin regulates Wnt/β-catenin signalling. ► Hsp90α/β chaperones cell signalling. ► Hsp90α/β co-localises with GSK3β, β-catenin and phospho-β-catenin. ► Hsp90α/β immunoprecipitates with phospho-β-catenin and axin1. ► This is the first report of phospho-β-caten...
Saved in:
Published in | Biochemical and biophysical research communications Vol. 413; no. 4; pp. 550 - 554 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
07.10.2011
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | ► Phosphorylation and degradation of β-catenin regulates Wnt/β-catenin signalling. ► Hsp90α/β chaperones cell signalling. ► Hsp90α/β co-localises with GSK3β, β-catenin and phospho-β-catenin. ► Hsp90α/β immunoprecipitates with phospho-β-catenin and axin1. ► This is the first report of phospho-β-catenin and axin1 as Hsp90α/β client proteins.
Hsp90α/β, the signal transduction chaperone, maintains intracellular communication in normal, stem, and cancer cells. The well characterised association of Hsp90α/β with its client kinases form the framework of multiple signalling networks. GSK3β, a known Hsp90α/β client, mediates β-catenin phosphorylation as part of a cytoplasmic destruction complex which targets phospho-β-catenin to the 26S proteasome. The canonical Wnt/β-catenin pathway promotes stem cell self-renewal as well as oncogenesis. The degree of Hsp90α/β involvement in Wnt/β-catenin signalling needs clarification. Here, we describe the association of Hsp90α/β with GSK3β, β-catenin, phospho-β-catenin and the molecular scaffold, axin1, in the human MCF-7 epithelial breast cancer cell model using selective inhibition of Hsp90α/β, confocal laser scanning microscopy and immunoprecipitation. Our findings suggest that Hsp90α/β modulates the phosphorylation of β-catenin by interaction in common complex with GSK3β/axin1/β-catenin. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0006-291X 1090-2104 |
DOI: | 10.1016/j.bbrc.2011.08.136 |